SIGN UP
LOG IN
Why Inari Medical Shares Are Trading Higher By 21%; Here Are 20 Stocks Moving Premarket
Benzinga·01/07/2025 12:15:03
Listen to the news
Shares of Inari Medical, Inc. (NASDAQ:NARI) rose sharply in today's pre-market trading after Stryker (NYSE:SYK) announced plans to acquire the company for $80 per share in cash.
Inari Medical shares jumped 21.2% to $78.79 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
Gainers
- MultiSensor AI Holdings, Inc. (NASDAQ:MSAI) gained 101% to $4.02 in pre-market trading after the company announced management appointments.
- Algorhythm Holdings, Inc. (NASDAQ:RIME) gained 86.3% to $0.2697 in pre-market trading after surging 30% on Monday.
- XTI Aerospace, Inc. (NASDAQ:XTIA) rose 61.9% to $0.1425 in pre-market trading after gaining around 113% on Monday.
- Healthy Choice Wellness Corp (NASDAQ:HCWC) rose 51.5% to $1.47 in pre-market trading after falling 12% on Monday. The company reported fourth-quarter financial results.
- Aurora Innovation, Inc. (NASDAQ:AUR) rose 47.1% to $9.59 in pre-market trading after the company partnered with Continental and NVIDIA to launch next-generation driverless trucks by 2027.
- DatChat, Inc. (NASDAQ:DATS) gained 34.1% to $2.63 in pre-market trading.
- Getty Images Holdings, Inc. (NYSE:GETY) gained 30.8% to $3.36 in pre-market trading. Getty Images and Shutterstock announced a merger agreement for $3.7 billion.
- Conduit Pharmaceuticals Inc. (NASDAQ:CDT) gained 17.3% to $0.0848 in pre-market trading. Conduit Pharmaceuticals, last month, announced it entered an agreement with Sarborg to leverage AI and its cybernetics platform to evaluate key deliverables across multiple areas of operations.
- Syra Health Corp. (NASDAQ:SYRA) gained 16.3% to $0.5700 in pre-market trading after gaining 9% on Monday.
Losers
- Boxlight Corporation (NASDAQ:BOXL) fell 25.6% to $1.25 in pre-market trading after jumping 265% on Monday.
- Splash Beverage Group, Inc. (NASDAQ:SBEV) fell 21.5% to $0.2120 in pre-market trading after jumping around 13% on Monday.
- CytoMed Therapeutics Limited (NASDAQ:GDTC) shares fell 20.8% to $2.72 in pre-market trading. CytoMed Therapeutics announced it entered into a business and research collaboration agreement with Mumbai-based SunAct Cancer Institute.
- Babcock & Wilcox Enterprises, (NYSE:BWNB) fell 19.1% to $17.00 in today's pre-market trading.
- Gold Resource Corporation (NYSE:GORO) fell 17.7% to $0.1880 in pre-market trading after announcing a $2.5 million registered direct offering.
- Kuke Music Holding Limited (NYSE:KUKE) shares fell 17.2% to $0.5549 in pre-market trading.
- Acelyrin, Inc. (NASDAQ:SLRN) dipped 15.4% to $2.95 in pre-market trading. ACELYRIN announced additional Phase 2 data and the Phase 3 program design for lonigutamab in Thyroid Eye Disease.
- Cogent Biosciences, Inc. (NASDAQ:COGT) shares tumbled 13.2% to $7.00 in pre-market trading.
- BP Prudhoe Bay Royalty Trust (NYSE:BPT) shares dipped 12.1% to $0.6789 in pre-market trading as the company announced no unit payment for the fourth quarter.
- Exicure, Inc. (NASDAQ:XCUR) declined 8.9% to $11.70 in pre-market trading after dipping more than 10% on Monday.
Now Read This:
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.